IXICO today announces its unaudited interim results for the six months ended 31 March 2014.
- Successful launch of Assessa®, our CE-marked digital healthcare platform for decision-support in dementia diagnosis
- Expansion in clinical trials and experimental medicine business
- Continuing business development in China
- Financial performance on budget and in-line with expectations